Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger

Hdl Handle:
http://hdl.handle.net/10144/619072
Title:
Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger
Authors:
Grandesso, F; Guindo, O; Woi Messe, L; Makarimi, R; Traore, A; Dama, S; Laminou, IM; Rigal, J; de Smet, M; Ouwe Missi Oukem-Boyer, O; Doumbo, OK; Djimdé, A; Etard, JF
Journal:
Malaria Journal
Abstract:
Malaria endemic countries need to assess efficacy of anti-malarial treatments on a regular basis. Moreover, resistance to artemisinin that is established across mainland South-East Asia represents today a major threat to global health. Monitoring the efficacy of artemisinin-based combination therapies is of paramount importance to detect as early as possible the emergence of resistance in African countries that toll the highest burden of malaria morbidity and mortality.
Publisher:
BioMed Central
Issue Date:
25-Jan-2018
URI:
http://hdl.handle.net/10144/619072
DOI:
10.1186/s12936-018-2200-1
PubMed ID:
29370844
Submitted date:
2018-01-31
Language:
en
ISSN:
1475-2875
Appears in Collections:
Malaria

Full metadata record

DC FieldValue Language
dc.contributor.authorGrandesso, Fen
dc.contributor.authorGuindo, Oen
dc.contributor.authorWoi Messe, Len
dc.contributor.authorMakarimi, Ren
dc.contributor.authorTraore, Aen
dc.contributor.authorDama, Sen
dc.contributor.authorLaminou, IMen
dc.contributor.authorRigal, Jen
dc.contributor.authorde Smet, Men
dc.contributor.authorOuwe Missi Oukem-Boyer, Oen
dc.contributor.authorDoumbo, OKen
dc.contributor.authorDjimdé, Aen
dc.contributor.authorEtard, JFen
dc.date.accessioned2018-02-06T16:37:26Z-
dc.date.available2018-02-06T16:37:26Z-
dc.date.issued2018-01-25-
dc.date.submitted2018-01-31-
dc.identifier.citationEfficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger. 2018, 17 (1):52 Malar. J.en
dc.identifier.issn1475-2875-
dc.identifier.pmid29370844-
dc.identifier.doi10.1186/s12936-018-2200-1-
dc.identifier.urihttp://hdl.handle.net/10144/619072-
dc.description.abstractMalaria endemic countries need to assess efficacy of anti-malarial treatments on a regular basis. Moreover, resistance to artemisinin that is established across mainland South-East Asia represents today a major threat to global health. Monitoring the efficacy of artemisinin-based combination therapies is of paramount importance to detect as early as possible the emergence of resistance in African countries that toll the highest burden of malaria morbidity and mortality.en
dc.language.isoenen
dc.publisherBioMed Centralen
dc.rightsPublished by BioMed Central, [url]http://www.malariajournal.com/[/url] Archived on this site by Open Access permissionen
dc.titleEfficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Nigeren
dc.identifier.journalMalaria Journalen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.